← Back to Search

Low dose RMT for Coronavirus

N/A
Waitlist Available
Led By Courtney M Wheatley-Guy, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to 4 weeks
Awards & highlights

Study Summary

This trial will study the effects of RMT and nasal breathing on patients with lingering symptoms from SARS-CoV2 infection.

Eligible Conditions
  • Coronavirus

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Phonation time
Change in Sit to stand executions
Change in breathing difficulty
+3 more

Trial Design

5Treatment groups
Experimental Treatment
Group I: Respiratory muscle training for strengthening and nasal breathingExperimental Treatment1 Intervention
Higher number of sets with a slightly lower number of repetitions per set RMT accompanied with sets of nasal breathing
Group II: Respiratory muscle training for strengtheningExperimental Treatment1 Intervention
Higher number of sets with a slightly lower number of repetitions per set
Group III: Respiratory muscle training for endurance and nasal breathingExperimental Treatment1 Intervention
One set of RMT with a higher number of repetitions accompanied with sets of nasal breathing
Group IV: Respiratory muscle training for enduranceExperimental Treatment1 Intervention
One set of RMT with a higher number of repetitions
Group V: Low respiratory muscle trainingExperimental Treatment1 Intervention
Low dose of RMT and fewer repetitions and use of RMT device per week
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Low dose RMT
2021
N/A
~2270
Endurance RMT and nasal breathing
2021
N/A
~2270
Strength RMT
2021
N/A
~2270
Strength RMT and nasal breathing
2021
N/A
~2270
Endurance RMT
2021
N/A
~2270

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,206 Previous Clinical Trials
3,764,815 Total Patients Enrolled
Courtney M Wheatley-Guy, PhDPrincipal InvestigatorMayo Clinic

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment presently taking place for this clinical trial?

"Affirmative. Clinicaltrials.gov indicates that this clinical trial, which became available on November 1st 2021, is actively seeking participants. A total of 1500 patients are being sought from a single site."

Answered by AI

What is the cap on the number of participants in this experiment?

"Affirmative, the clinicaltrials.gov data suggests that this experiment is recruiting at present. It was first advertised on November 1st 2021 and last updated on June 6th 2022, with 1500 patients being sought from a single medical centre."

Answered by AI

Who else is applying?

What state do they live in?
Pennsylvania
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Covid-19 Virtual Recovery Study
Courtney M. Wheatley 2021. "Covid-19 Virtual Recovery Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04950725.
~664 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top